Lunit announced the appointment of Teri Thomas as Chief Business Officer (CBO) of its Cancer Screening Group, effective July 1, 2024. While taking on this additional role, Thomas will continue serving as CEO of Volpara Health Technologies, which Lunit acquired in May 2024. Thomas, an American based in New Zealand, brings over 25 years of executive management experience in healthcare IT to her new role.

Her expertise spans strategy, operations, global sales, marketing leadership, with a deep understanding of the US healthcare market. Thomas's career includes a notable 20-year tenure at Epic, a global healthcare systems provider, where she played a pivotal role in the company's growth from under 100 employees to over 10,000. As a registered nurse with a Master of Science degree, Thomas offers a unique perspective on the intersection of IT, clinician workflow, and patient experience.

Her background includes executive roles at population health firm Orion Health and leading IT innovation at the University of North Carolina Health Care. In her expanded role, Thomas will spearhead sales and marketing efforts for both Lunit and Volpara Health. She will focus on expanding Lunit's business in the US and EMEA (Europe, Middle East and Africa) markets in 2024, followed by further territorial expansion from 2025 onward.